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Diagnostic performance of a reverse transcription-polymerase chain reaction test for porcine reproductive and respiratory syndrome virus
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Porcine reproductive and respiratory syndrome (PRRS) virus first appeared in swine in Canada in the late 1970s, in the United States in the mid 1980s, and in Europe in 1990. 23 Since that time, PRRS virus infection has become endemic in most pork-producing areas of the world. Although infection is frequently subclinical, PRRS virus plays a significant role in swine health, as reflected in the number of cases submitted to veterinary diagnostic laboratories located in swine-dense areas. For instance, in 1998 the Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL) performed 90,608 serologic tests for the detection of PRRS virus antibody (J. Zimmerman, personal communication), and among diagnostic cases involving swine, 83% of samples (5,026/6,023) submitted for virus isolation included a request for isolation of PRRS virus (K.-J. Yoon, personal communication).
Economically, PRRS is generally perceived to be the most significant infectious disease of swine in North America. Over the last several years, the economic impact of PRRS virus on swine production has stimulated a substantial investment of research resources into the search for effective disease control strategies. The development of accurate and rapid diagnostic assays has been an essential part of this effort. Numerous procedures have been developed and implemented for the diagnosis of PRRS, including serum antibody assays, virus isolation techniques, and antigen detection and visualization in tissues by immunohistochemistry or immunofluorescence microscopy. 24 In addition, a number of polymerase chain reaction (PCR) assays and in situ hybridization techniques have been developed for the detection of PRRS virus RNA in clinical specimens, including serum, semen, and tissues. 4, [9] [10] [11] [12] 16, 17 The transfer of PCR technology into the diagnostic setting has been of particular interest to diagnosticians and swine practitioners. Generally, PCR is considered to offer distinct advantages over other techniques, including faster availability of results, higher diagnostic sensitivity, and higher diagnostic specificity. At the present time, however, documentation of the specific diagnostic performance characteristics of PCR assays is sparse. Here, we report observations on the diagnostic performance of a PCR assay for the detection of PRRS virus.
The original intent of this research was to use a reverse transcription-nested PCR (RT-nPCR) to detect PRRS virus genomic material in field samples collected from 20 commercial swine herds. Field samples (n ϭ 756) were submit-ted to a midwestern US laboratory performing PRRS virus RT-nPCR on a commercial basis. To facilitate the interpretation of PCR results for field samples, 337 samples of known status were submitted with the field samples. These samples were included to provide estimates of diagnostic sensitivity, diagnostic specificity, and analytic sensitivity: serum from 195 individual swine negative for PRRS virus infection were included to estimate diagnostic specificity, i.e., the probability that a sample from individual free of PRRS virus infection would test negative; serum from 102 individual swine experimentally inoculated with PRRS virus were included to estimate diagnostic sensitivity, i.e., the probability of a positive test result from an infected individual; and 40 samples ''spiked'' with PRRS virus were included to estimate the analytic sensitivity of the assay, i.e., the minimum detectable quantity of virus per milliliter.
The serum samples from animals of known PRRS virus infection status were acquired in the course of conducting PRRS virus-related research at the ISU-VDL. All 195 animals originated from either of 2 PRRS virus-free herds. These herds had been clinically, virologically, and serologically monitored for PRRS virus infection over a period of several years. To confirm their negative status, animals were tested for the presence of antibodies against PRRS virus using a commercial enzyme-linked immunosorbent assay (ELISA) a and/or virus isolation (VI) was attempted using porcine alveolar macrophages (PAMs) and/or MARC-145 cells. 8 All animals were negative for antibodies and/or PRRS virus by these tests. Of the 195 negative pigs, 102 were intranasally inoculated under experimental conditions with the same lot of PRRS virus (isolate ISU-P). 21 Serum samples collected on postinoculation (PI) day 7 were used as known positive samples to estimate diagnostic sensitivity. The use of PI day 7 samples as positive controls was justified on the basis of our experience with PRRS virus and of numerous publications indicating that pigs infected with PRRS virus are viremic on PI day 7. 3, 5, [13] [14] [15] 19, 21 Of the 102 experimentally infected animals, VI from PI day 7 serum samples was attempted on 85 pigs, and all were VI positive. VI was not done on the remaining 17 pigs, but all were ELISA positive by PI day 21 or earlier.
To estimate the analytic sensitivity of the assay, serum from 7 7-week-old PRRS virus-negative pigs was pooled and then divided into 4 aliquots. Three aliquots were spiked with PRRS virus (isolate ISU-P) to yield titers of approximately Ͻ10 1 , 10 1 , or 10 2 fluorescent foci units (FFU)/ml. The fourth aliquot received no virus (negative control). To estimate the actual quantity of virus in spiked samples, virus titration was done on a sample from each of the 3 different levels using a modification of a microtitration infectivity assay described elsewhere. 20 The amount of virus in each sam- ple was determined at 70 hours PI and expressed as the mean number of infected cell foci at a given dilution. Foci of infected cells were detected by staining inoculated cells with anti-PRRS virus monoclonal antibody SDOW17 b conjugated with fluorescein isothiocyanate. The actual amount of infectious PRRS virus in the 3 spiked samples was calculated to be 3.2 FFU/ml, 0.9 ϫ 10 1 FFU/ml, and 1.3 ϫ 10 2 FFU/ml. Ten samples of 1 ml each were submitted for RT-nPCR assay from each of the 4 aliquots.
To avoid bias, all 1,093 samples (field samples, samples of known status, and spiked samples) were completely randomized and renumbered prior to submission.
The RT-nPCR was performed as follows. Prior to extraction of viral nucleic acid, serum samples were spiked with 20 atagrams of internal control RNA (J30), an in vitro polyadenylated transcript (2.1 kb) representing a portion of the sequence of open reading frames (ORFs) 2-7 of PRRS virus and containing a 0.1-kb deletion in the amplified section (ORFs 6 and 7). RNA from 200 l of serum was isolated using the QIAmp kit c according to the manufacturer's specifications. One fifth of the extracted RNA, internal control RNA, and 500 ng of oligo d(T) were incubated at 70 C for 10 minutes and then placed on ice. RNA was reverse transcribed using 200 U of SuperScript reverse transcriptase II RNaseH d at 42 C for 50 minutes, enzyme was inactivated by heating at 72 C for 10 minutes, and cDNA was stored at Ϫ20 C until needed. The cDNA was amplified using 2.5 U of TaqPLUS Long e in 1 ϫ low salt buffer with the primary primers (20 pmol) for 20 cycles, after an initial denaturation step at 93 C for 4 minutes. Cycle parameters were 93 C for 4 seconds, 55 C for 30 seconds, and 72 C for 45 seconds. Cycles were followed by a further incubation at 72 C for 9 minutes. Primary amplified products were subjected to additional cycles of amplification using nested primer pairs under the same reaction conditions. Primary and nested primers were designed to target ORFs 6 and 7 based on alignment of multiple PRRS virus sequences available in GenBank and in privately held collections. PCR products were separated on 2.0% Tris-acetate-ethylendrammetatraacetic acid agarose gels and visualized by staining with ethidium bromide. The presence or absence of the native PRRS virus band (389 base pairs) was used to diagnose positive and negative samples. Samples which failed to show the J30 internal control band (289 base pairs) were reanalyzed.
The results of the PRRS virus RT-nPCR assay are summarized in Table 1 . Using RT-nPCR results from the 102 experimentally infected animals, the diagnostic sensitivity of the assay was 25.5% and diagnostic specificity was 96.4%. Using only RT-nPCR results from the VI-positive serum samples, diagnostic sensitivity was estimated to be 23.5% (20/85). After this outcome was reported back to the laboratory, a subset of the samples of known status was resubmitted and reanalyzed at the laboratory's request. The subset consisted of samples from 174 known-negative and 93 known-positive animals. These samples were again randomly ordered to prevent bias. No field samples were submitted because the purpose of the second submission was only to estimate test performance. Among all positive samples, diagnostic sensitivity in the second submission was 68.8% and diagnostic specificity was 99.4% (Table 1 ). Among the VIpositive samples, 53 of 77 (68.8%) were RT-nPCR positive.
With respect to analytic sensitivity, 2 of the 30 spiked samples were positive on the first submission. After resubmission, PRRS virus RNA was detected in 10 of 10 samples containing 1.3 ϫ 10 2 FFU/ml, 6 of 10 samples containing 0.9 ϫ 10 1 FFU/ml, 0 of 10 samples containing 3.2 FFU/ml, and 0 of 10 samples containing no virus. Thus, on the second submission, the assay had a 60% probability of detecting viral RNA in samples containing approximately 10 virions/ ml.
Differences in conducting the assay help explain the difference in performance between the first and second submissions. The laboratory conducting the assay indicated that RNA extracted from samples in the first submission were stored at Ϫ80 C until RNA from all samples was isolated before the amplification step was conducted. In the second submission, extracted RNA was not stored but was immediately put through the PCR procedure. The level of internal control was also changed slightly from the first submission to the second to reduce competition between the internal control and the sample nucleic acid for primer. Additionally, the laboratory converted sample preparation to a 96-well format, which increased throughout and decreased sample standing time.
The observed level of test performance in the optimized assay (second submission) was lower that expected, but the 68.8% diagnostic sensitivity in this study was compatible with PRRS virus PCR performance reported previously, 12 where diagnostic sensitivity for a PRRS virus RT-PCR procedure was 75% for lung tissues (n ϭ 4) collected from experimentally infected pigs between 4 and 10 days PI. All 4 of those samples were VI positive on PAMs. The data in our study were also comparable with PCR performance reported for other infectious agents. An n-PCR procedure for the detection of feline infectious peritonitis virus was estimated to be 92% diagnostically sensitive and 94% diagnostically specific; 7 a PCR assay for infectious laryngotracheitis virus in chickens was 27% diagnostically sensitive and 100% specific. 1 A PCR procedure for the detection of small ruminant lentiviruses had an analytic sensitivity of Ͻ10 DNA templates, but the diagnostic sensitivity was lower than that of an ELISA for detection of antibody and had a diagnostic specificity of only 50%. 22 Sources of misclassification errors in PCR-based assays include false positives as a result of contamination from other samples 2, 11 and false negatives due to inhibitory factors in sample extracts. 11 In terms of analytic sensitivity, reports on PRRS virus PCR methods vary widely. Among those that reported analytic sensitivity in terms of the minimum number of virions detected per unit volume, estimates ranged from 10 to 30 infectious particles/ml. 4, 18 These published estimates are comparable to the analytic sensitivity estimated in the present study for retest samples. Some investigators reported analytic sensitivity in terms of TCID 50 . These estimates ranged from a low of 10 Ϫ2 TCID 50 to a high of 10 2 TCID 50 . 11, 17 Because TCID 50 is an estimate of virus concentration based on a quantal assay rather than a quantitative assay, it is not possible to estimate the actual number of infectious particles detected by these assays. 6 For that reason, it is more useful to report PCR analytic sensitivity as the minimum number of virions detected. Based on the data reported here, there does not appear to be a threshold level of virus concentration above which the test always detects virus and below which it does not. In this study, as virus concentration declined to lower levels false negatives appeared with increasing frequency. For that reason, studies of PCR analytic sensitivity should be carried out at several levels of virus concentration and with a sufficient number of samples at each virus concentration level to make it possible to estimate the probability function curve.
Animal health specialists and diagnosticians are constantly seeking better tools for the diagnosis, prevention, and control of infectious agents. In the particular case of PRRS virus, rapid and accurate assays for the identification of persistently infected carrier animals and for the certification of semen as PRRS virus free are essential. Many veterinary practitioners and diagnosticians had assumed that PCR-based assays would meet this need and provide nearly perfect diagnostic performance, with neither false-positive nor false-negative results. The results of this and previous studies do not support this assumption. However, these results have a very short shelflife. Molecular microbiology is evolving rapidly, and current assays will be replaced by future assays based on advances in molecular technology. From a broader perspective, perhaps a more important lesson from this exercise is an old one, i.e., assume nothing and, regardless of the diagnostic technology utilized (conventional or molecular), evaluate diagnostic performance, optimize sample selection, and compare with other diagnostic techniques before implementing a new assay in the diagnostic setting. 
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